RDSNF (Redsense Medical AB) Cyclically Adjusted Revenue per Share: $0.14 (As of Mar. 2026)


RDSNF Redsense Medical AB RDSNF
64 GF Score
Price $0.51
GF Value $0.82
! 5 Warning Signs
View Full Analysis

What is Redsense Medical AB Cyclically Adjusted Revenue per Share?

Redsense Medical AB RDSNF -51.43% 64 Cyclically Adjusted Revenue per Share is $0.14 as of Mar. 2026. GuruFocus rates RDSNF with a GF Score™ of 64/100 and a GF Value™ of $0.82. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Redsense Medical AB's adjusted revenue per share data for the fiscal year that ended in Dec. 2025 was $0.159. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.14 for the trailing ten years ended in Dec. 2025.

During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 19.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Redsense Medical AB was 19.80% per year. The lowest was 19.80% per year. And the median was 19.80% per year.

As of today (2026-07-08), Redsense Medical AB's current stock price is $ 0.51. Redsense Medical AB's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec. 2025 was $0.14. Redsense Medical AB's Cyclically Adjusted PS Ratio of today is 3.64.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Redsense Medical AB was 18.13. The lowest was 2.75. And the median was 7.14.


Redsense Medical AB  (OTCPK:RDSNF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Redsense Medical AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.51/0.14
=3.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Redsense Medical AB was 18.13. The lowest was 2.75. And the median was 7.14.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Redsense Medical AB Cyclically Adjusted Revenue per Share Related Terms


Redsense Medical AB Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Redsense Medical AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redsense Medical AB Cyclically Adjusted Revenue per Share Chart

Redsense Medical AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.11 0.07 0.14

Redsense Medical AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.14 0.00

RDSNF vs ABT, SYK, MDT: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Redsense Medical AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Redsense Medical AB Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Redsense Medical AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Redsense Medical AB's Cyclically Adjusted PS Ratio falls into.


RDSNF
64GF Score
Redsense Medical AB RDSNF
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Redsense Medical AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Redsense Medical AB's adjusted Revenue per Share data for the fiscal year that ended in Dec. 2025 was:

Adj_RevenuePerShare=Revenue per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=0.159/133.3900*133.3900
=0.159

Current CPI (Dec. 2025) = 133.3900.

Redsense Medical AB Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201612 0.053 102.022 0.069
201712 0.018 103.793 0.023
201812 0.071 105.912 0.089
201912 0.115 107.766 0.142
202012 0.123 108.296 0.152
202112 0.073 112.486 0.087
202212 0.098 126.365 0.103
202312 0.173 131.912 0.175
202412 0.150 132.987 0.150
202512 0.159 133.390 0.159

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $0.14 mean?
Redsense Medical AB (RDSNF) has a Cyclically Adjusted Revenue per Share of $0.14 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Redsense Medical AB and its competitors.
Is Redsense Medical AB's Cyclically Adjusted Revenue per Share too high?
Redsense Medical AB's current Cyclically Adjusted Revenue per Share is $0.14. Overall, Redsense Medical AB has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Redsense Medical AB's Cyclically Adjusted Revenue per Share compare to ABT and SYK?
Redsense Medical AB's Cyclically Adjusted Revenue per Share of $0.14 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Redsense Medical AB and its competitors. Redsense Medical AB's current Cyclically Adjusted Revenue per Share is $0.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redsense Medical AB stock overvalued right now?
Redsense Medical AB (RDSNF) has a current Cyclically Adjusted Revenue per Share of $0.14. The stock's GF Value™ is $0.82, compared to a current price of $0.51 — trading 37.8% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $0.14. Redsense Medical AB's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Redsense Medical AB (RDSNF), the current Cyclically Adjusted Revenue per Share is $0.14 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Redsense Medical AB (RDSNF) Overvalued in 2026?

Based on GuruFocus' analysis, Redsense Medical AB stock appears to be undervalued. The current stock price of $0.51 is trading 37.8% below its estimated GF Value™ of $0.82.

Key valuation signals for RDSNF:

  • Cyclically Adjusted Revenue per Share: $0.14
  • GF Value™: $0.82 vs. price of $0.51 (37.8% below fair value)
  • GF Score™: 64/100 with 5 warning signs

No single metric tells the full story. See the RDSNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Redsense Medical AB Business Description

Other Exchanges REDS:Sweden
Address Storgatan 36, Halmstad, SWE, 302 43
Redsense Medical AB manufactures and sells blood loss detection devices in Sweden. The company has developed a monitoring system that can detect the first sign of a blood leak using patented fiber optic technology. The products of the company include Alarm Unit, Venous Needle Patch, Sensor Patch, and others.
64GF Score

Get the complete analysis for RDSNF

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.51
Price
$0.82
GF Value